Using Tai Chi and Qigong to Treat Parkinson’s Disease: Utilizing Artificial Intelligence to Summarize 7 Traditional Chinese Medicine Studies
Keywords:
Tai Chi, Qigong, Parkinson's disease, balance, motor function, gait, meta-analysis, randomized controlled trial, complementary therapy, neuroplasticity, fall preventionAbstract
Parkinson’s disease is characterized by progressive motor impairment and a wide range of non‑motor symptoms that remain only partially controlled by conventional pharmacotherapy. Tai Chi and Qigong, two traditional Chinese mind–body practices, have been increasingly investigated as complementary approaches for patients with Parkinson’s disease. This article uses an artificial intelligence assistant to collate and summarize findings from 7 key publications—primarily systematic reviews, meta‑analyses, and randomized controlled trials—together with additional recent clinical and mechanistic studies on Tai Chi and Qigong in this population. Across these reports, Tai Chi and Qigong are consistently associated with improvements in balance, postural stability, functional mobility, and fall rates, with several trials also demonstrating benefits in motor scores, sleep, mood, cognition, and health‑related quality of life. Emerging mechanistic work suggests that these practices may exert their effects through enhanced neuromuscular control, modulation of brain network connectivity, anti‑inflammatory and antioxidant pathways, and improved neuroplasticity. At the same time, the evidence base remains constrained by heterogeneous protocols, limited long‑term follow‑up, and variable methodological quality in some reviews. Overall, current data support Tai Chi and Qigong as safe, feasible, and potentially valuable adjuncts to standard care for Parkinson’s disease, and highlight the utility of artificial intelligence tools for efficiently synthesizing an evolving literature.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Copyright © 2026 by the Author(s). Published by Neo-ART Excellence Hub Pvt. Ltd. This article is distributed under the Creative Commons Attribution 4.0 License (CC BY 4.0). Authors retain copyright and grant the publisher the right to publish and distribute the work. https://creativecommons.org/licenses/by/4.0/

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Clinical and Advanced Medicine (JCAM) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license allows anyone to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, as long as appropriate credit is given to the original author(s) and the source.
License link: https://creativecommons.org/licenses/by/4.0/